1. Zhou, Jin, Simon, Jeremy M, Liao, Chengheng, Brugarolas, James, Zhang, Qing. 2022. An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma. In Molecular cell, 82, 3030-3044.e8. doi:10.1016/j.molcel.2022.06.003. https://pubmed.ncbi.nlm.nih.gov/35764091/
2. Raguz, Nikoleta, Heim, Astrid, Engal, Eden, Salton, Maayan, Böttger, Angelika. 2020. JMJD6 Regulates Splicing of Its Own Gene Resulting in Alternatively Spliced Isoforms with Different Nuclear Targets. In International journal of molecular sciences, 21, . doi:10.3390/ijms21186618. https://pubmed.ncbi.nlm.nih.gov/32927736/
3. Wang, Kai, Yang, Chao, Li, Haibin, Mei, Zhiqiang, Wang, Haiyong. 2022. Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response. In Frontiers in immunology, 13, 859893. doi:10.3389/fimmu.2022.859893. https://pubmed.ncbi.nlm.nih.gov/35359945/
4. Wang, Lei, Wen, Mingyue, Cao, Xuetao. 2019. Nuclear hnRNPA2B1 initiates and amplifies the innate immune response to DNA viruses. In Science (New York, N.Y.), 365, . doi:10.1126/science.aav0758. https://pubmed.ncbi.nlm.nih.gov/31320558/
5. Kosai-Fujimoto, Yukiko, Itoh, Shinji, Yugawa, Kyohei, Yoshizumi, Tomoharu, Mori, Masaki. 2022. Impact of JMJD6 on intrahepatic cholangiocarcinoma. In Molecular and clinical oncology, 17, 131. doi:10.3892/mco.2022.2564. https://pubmed.ncbi.nlm.nih.gov/35911665/
6. Wong, Matthew, Sun, Yuting, Xi, Zhichao, George, Rani E, Liu, Tao. 2019. JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma. In Nature communications, 10, 3319. doi:10.1038/s41467-019-11132-w. https://pubmed.ncbi.nlm.nih.gov/31346162/
智鼠故事 
